As of February 28, 2025, 99 patients were enrolled (Phase 1a, n=8; Phase 1b, n=6, Phase 2, n=30, 25, and 30 in Cohorts A, B, and C, respectively). The baseline characteristics are summarized below: ...

The potential of a Star Wars Battlefront 3 seems more enticing than ever after Fortnite's recent season and a resurgence of ...

Thin films of isotactic polybutene-1 (iPBu) with large lathlike flat-on form II crystals were prepared by isothermal crystallization from melt at 105 °C. The II–I phase transition of this kind of thin ...

Dive deep into the Star Wars universe with a full breakdown of every single Clone Trooper Battalion, Legion, and Corps. From iconic units like the 501st to lesser-known divisions, this guide ...

The trooper was also taken to R Adams Cowley Shock Trauma Center, where he was treated and released, officials said. The GMC driver was taken to Howard County General Hospital for treatment. The ...

A Jeep slammed into a trooper’s cruiser on I-95 in Maryland, setting off a five-vehicle crash that killed one person and led to a DUI arrest, state police said.The crash was reported shortly after 2 a ...

Zero Company could include Star Wars legends that did a lot of battling during the three-year-long Clone Wars conflict, but for the most part, we're expecting it to keep things shadowy, dirty, and ...

Additionally, Sagimet recently initiated a Phase 1 first-in-human clinical trial with a second FASN inhibitor, TVB-3567, that is planned to be developed for acne in the US.

Sionna plans to advance both NBD1 stabilizers to the next stage of clinical development — SION-719 to a Phase 2a proof-of-concept (POC) trial in CF patients as an add-on to SOC, and SION-451 to ...

PD-1/IL-2 α-bias bispecific antibody fusion protein IBI363 in patients with immunotherapy resistant advanced non-small cell lung cancer: results from a Phase 1 study Updated data on IBI363 monotherapy ...

Objective To evaluate the efficacy and safety of the Janus kinase-1-preferential inhibitor filgotinib versus placebo or tumour necrosis factor-α inhibitor therapy in patients with active rheumatoid ...